Mirae Asset Global ETFs Holdings
STLN

Mirae Asset Global ETFs Holdings’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
37,383
+5,717
+18% +$17.5K ﹤0.01% 2601
2025
Q4 		$113K Buy
31,666
+4,514
+17% +$16.7K ﹤0.01% 2624
2025
Q3 		$94.8K Sell
27,152
-5,108
-16% -$17.5K ﹤0.01% 2689
2025
Q2 		$66.1K Buy
+32,260
New +$80.7K ﹤0.01% 2802

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's STLN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 18% in Q1 2026, buying an estimated $17.5K and bringing the position to 37,383 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Mirae Asset Global ETFs Holdings first reported a position in STLN in Q2 2025 and has held it in 4 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 37,383 shares of Starling Oncology Institute, Inc. Common Stock worth $115K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 5,717 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $17.5K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2601 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.